Characterization and bioavailability of danazol-hydroxypropyl β-cyclodextrin coprecipitates
- 29 February 1996
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 128 (1-2) , 45-54
- https://doi.org/10.1016/0378-5173(95)04214-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The Impact of Lag Time on the Estimation of Pharmacokinetic Parameters. I. One-Compartment Open ModelPharmaceutical Research, 1993
- Improvements in Solubility and Stability of Thalidomide upon Complexation with Hydroxypropyl-β-CyclodextrinJournal of Pharmaceutical Sciences, 1992
- Effects of ethanol on formation of inclusion complexes of hydroxypropylcyclodextrins with testosterone or with methyl orangeInternational Journal of Pharmaceutics, 1992
- Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM): Treatment with an Anabolic Steroid DanazolAIDS Research and Human Retroviruses, 1991
- Single oral dose pharmacokinetics and comparative bioavailability of danazol in humansBiopharmaceutics & Drug Disposition, 1991
- Solubilization and Wetting Effects of Bile Salts on the Dissolution of SteroidsPharmaceutical Research, 1991
- Moisture Adsorption-desorption Effect on the Structure of Inclusion Complex of 6-Chloro-2-pyridylmethyl Nitrate and β-CyclodextrinJournal of Pharmacy and Pharmacology, 1990
- Improvement of the in vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrinInternational Journal of Pharmaceutics, 1990
- Inclusion of retinoic acid in β-cyclodextrinInternational Journal of Pharmaceutics, 1989
- Analysis of danazol in serum using high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987